What is LSAK's health score?

LESAKA TECHNOLOGIES INC (LSAK) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is LSAK's estimated fair value?

Based on our 5-year discounted cash flow model, LESAKA TECHNOLOGIES INC's estimated fair value is $3.71 per share, representing a -26.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is LSAK undervalued or overvalued?

Our model currently rates LSAK as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for LSAK... Refresh in a moment for the full analysis.

LESAKA TECHNOLOGIES INC (LSAK)

Financials Overvalued low weak

$5.06

Updated: 2026-06-05

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

55 Mixed

Risk

50 Mixed

Est. Fair Value $3.71

DCF Upside -26.6%

Sector Rank #166 of 6378

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.